INTRODUCTION {#sec1-1}
============

Various methods have been developed for the assessment of kidney function. Every method has its own limitations. The measurement of Glomerular filtration rate (GFR) is based on the concept of clearance\[[@ref1]\] through the kidneys. Urea, insulin, and creatinine clearance (CrCl) tests are used to examine impairment of glomerular filtration. Although, inulin clearance is considered as gold standard but this method is impractical for routine use due to cumbersome methodology. 99m-Technitium labeled Di-ethyl Triamine Penta Acetic acid (Tc99m-DTPA) clearance as renogram with the gamma camera method is much simpler and popular in routine clinical practice compared to plasma sampling method to measurement of GFR. Gamma camera Di-ethyl Triamine Penta Acetic Acid (DTPA) renogram provides GFR\[[@ref2][@ref3]\] to know the split kidney function as well.

At the same time estimated Serum creatinine clearance (SCrCl)\[[@ref4]\] with the Cockcroft and Gault\'s formula is simple and easy to know the instant global kidney function. Taking various logistics into account serum creatinine although, is not an ideal filtration marker, however, its clearance may be regarded as standard for overall kidney function evaluation\[[@ref5]\] specially, in the regions where radionuclide facility is limited and/or patient cannot afford the DTPA renogram. The estimated CrCl is the choice of investigation for assessing the functional status of kidneys. In this present study, it has been tried to establish the validity of estimated SCrCl from serum creatinine using Cockcroft and Gault\'s formula in relation to GFR measured by using radionuclide gamma camera method as a marker of renal dysfunction.

MATERIALS AND METHODS {#sec1-2}
=====================

All the data of patients in the present retrospective study was collected from nuclear medicine record room data includes serum creatinine levels and the value of GFR by gamma camera method of the same patient with the time line. Freeze dried DTPA kit (TCK-7) procured from board of radiation and isotope technology was labeled by adding 50-60 mCi in 3-4 ml of Technetium-99m sodium pertechnetate following manufacturer\'s protocol. Planar gamma camera (ECIL, Hyderabad) fitted with low energy all purpose (LEAP) collimator was used to measure GFR of all the patients. Fifty nine patients of age between 5 years and 55 years were selected and CrCl was calculated using the formula of CG. Then the CrCl was normalized to a standard body surface area of 1.73 m^2^. In adult patient, generally, 3-4 mCi Tc99m-DTPA is administered intravenously through bolus injection. Injection and data acquisition is started simultaneously and the data is acquired in frame mode. The four frames between 120 s and 180 s were added to form a composite image of 2-3 min. Regions of interest were drawn around each kidney while background region was drawn lateral to each kidney.

The GFR is calculated using gate\'s formula in renal software. Patient height (in cm) weight (in kg), age (in years) and sex are fed as input according to the program. Now percentage of injected dose (% ID) is calculated for each kidney.
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Where, % ID = Percentage injected dose

I = Injected activity (in MBq)

*S* = Camera sensitivity (in Cts/min/MBq)

*K* = Kidney region (Cts/min)

*B* = Background region (Cts/min)

*D* = Depth correction

GFR is calculated from Gates formula

GFR (ml/min/1.73 Sqm) = (% ID left + % ID right) × 9.8127 − 6.8252

RESULTS {#sec1-3}
=======

All data has been divided into three groups based on the time difference between the Serum Creatinine test and 99mTc-DTPA renal GFR tests performed on the same subjects.

Group-I (*n* = 15 subjects) consists serum creatinine tests performed within ± 3 days from DTPA GFR test.Group-II (*n* = 17 subjects) consists serum creatinine test performed within ± 4-7 days from DTPA GFR test.Group-III (*n* = 27 patients) serum creatinine tests performed within ± 8-21 days from DTPA GFR test.

The detailed results have been depicted in Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"}. The correlation coefficient of Group-I (r~1~) is obtained 0.8198 and *P* value is \< 0.001. Therefore, significant level is 99.9%. The correlation coefficient of Group-II (r~2~) is found 0.6199 and *P* value is \< 0.01 and significant level is 99%. The correlation coefficient of Group-III (r~3~) is observed 0.5894 and *P* value is \< 0.01 and significant level is up to 99%.

###### 

Comparison of serum creatinine clearance and glomerular filtration rate measurement performed between 3 days
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###### 

Comparison of serum creatinine clearance and glomerular filtration rate measurement performed between 7 days
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###### 

Comparison of serum creatinine clearance and glomerular filtration rate measurement performed between 21 days
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DISCUSSION {#sec1-4}
==========

SCrCl by Cockcroft and Gault\'s formula shows close correlation between GFR measured by 99mTc-DTPA using scintigraphy. Statistical analysis of the three groups reveals that the value of correlation coefficient of Group-I is more than that of the Group-II and that of Group-II is more than Group-III. The serum creatinine also holds well with probability of occurrence of the Correlation coefficients i.e., *P* value. The data shows that the level of significance of Group-I is much more than that of Group-II and III. This implies than more nearly the time of measurements of serum creatinine level to the measurement of GFR of the patient, more is the value of correlation coefficients. Probably disease associated with patient may be one of the factors of different in the value of correlation coefficient that means disease would have been progressing during that time interval and i.e., why poor correlation in Group-II have been obtained.

Since, the present study is of retrospective nature, it is obvious to have some drawback. It would be better to conduct a prospective study disease wise. Their good correlation may exist in the three groups. Each indicates that serum creatinine may be a tool for the evaluation of kidney functions where nuclear medicine facilities are not commonly available. There is less number of specialized health center as well as limited resources for such a large population. Quick decision to see a kidney functional status of patient is required. In such situation, SCrCl using Cockcroft and Gault\'s formula may serve the purpose because this method has proven accuracy and is easier to perform than any other method of kidney function evaluation. SCrCl value and gamma camera method GFR on the same patient can be complementary for assessing any instrumental error incurred to check quality performance of gamma camera; if any; to both nuclear physicians and quality control managers in nuclear medicine. On the other hand, GFR measured by 99mTc-DTPA scintigraphy\[[@ref6][@ref7]\] is also significant because of its accuracy and reproducibility of the measurement being very high. It is a fast and easy method being computerized and through this method differential kidney GFR can be determined.
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